Navigation Links
Webinar Explores Drug Safety Lessons Pharma Can Learn from Airline Industry
Date:9/14/2009

WILMINGTON, Del., Sept. 14 /PRNewswire/ -- The airline and pharmaceutical industries both provide products and services that benefit mankind but which also can be dangerous if the risks are not properly calculated and dramatically lessened - but can drug manufacturers really learn from the experience of people who make and fly airplanes?

"Yes" is the conclusion of two experts who conducted a recent webinar on the topic - Captain Ben Berman, senior research associate at San Jose State University/NASA Ames Research Center and former chief of major investigations for the National Transportation Safety Board, and Jeffrey Fetterman, CEO of ParagonRx, a Delaware-based company specializing in maximum drug utilization, and author of several books and articles on pharmaceutical risk management. The webinar can be viewed at http://www.paragonrx.com/experience/webinars/pharmaceutical-risk-management-lessons-from-the-airline-industry---august-2009/

"The airline industry has vast experience in risk management systems that drug and devices manufacturers can learn from, especially in preparing FDA-mandated Risk Evaluation and Mitigation Strategy or REMS programs," Fetterman says.

Among the topics discussed in the webinar are how the airline industry concentrates on anticipating and mitigating risks, institutes formal safety management systems and employs redundancies or backups where risks are particularly severe. Earlier this year, Fetterman testified before an FDA REMS meeting on long-lasting opioid drugs and told how one airline safety approach - failure mode and effect analysis or FMEA - has particular relevance to drug safety management for powerful pain medications.

For information abo
'/>"/>

SOURCE ParagonRx
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Perot Systems Webinar to Provide Industry Perspective on Health Information Exchanges
2. Insite Security Hosts Webinar on Swine Flu Preparedness
3. The Beryl Institute Sponsors Free Customer Service Webinar with Robert Reiss
4. reThinking eHealth Webinar Announced - eHealth Experience Officer Needed Will a New Hospital Executive Emerge as Health Care Reforms?
5. Morehead Presents Webinar on 'He Said…She Said: How Gender Differences Impact Physician Engagement'
6. PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce
7. Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness, Grief and Loss
8. Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes
9. User Centric to Present Health IT Usability Webinar Series
10. Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units
11. Attendance on Demand, Inc. Hosts Free Webinar Top 5 Tools to Control Labor Costs for Long-Term Healthcare Professionals 2:30pm EDT August 26, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... DIEGO, Dec. 15 "The entire San Diego ... the passing of Sol Price on December 14, 2009. ... of integrity, loyalty and ethics in his business, community ... thoughtful humanitarian who truly understood the responsibility of philanthropy ... his legacy will live on through his countless philanthropic ...
(Date:12/15/2009)... UT Southwestern Medical Center researchers have provided ... unique observable characteristics seen in patients with an ... reported online and in the December issue of ... suggest that patients with atypical progeroid syndrome ... diagnosed with two similar but more well-defined accelerated ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... Dec. 14 Abbott (NYSE: ... agreement to acquire STARLIMS Technologies Ltd. (Nasdaq: ... laboratory information management systems, for approximately $123 ... strengthens Abbott,s competitive position in the global ... help laboratories efficiently store, retrieve and analyze ...
(Date:12/14/2009)... Dec. 14 Haemonetics Corporation (NYSE: ... filed a new legal action to stop Fenwal ... released red cell collection kits, using a modified ... chamber to circumvent Haemonetics, patent and the injunction ... of infringing products after December 1, 2010. ...
Breaking Medicine News(10 mins):Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3
... Kathryn Atchison is the recipient of the 2008 Behavioral, ... by the International Association for Dental Research (IADR) at ... on July 2, 2008., Dr. Atchison is a Professor ... School of Dentistry and the Vice-,Provost of Intellectual Property ...
... New research that explores,the tactics and strategies that ... available in the Best Practice Database, an,online research repository ... To review sample key findings and key metrics in ... each study at this address:, http://www3.best-in-class.com/dr319.htm , The ...
... could open the door to improved treatments , , WEDNESDAY, June ... that may make it easier for people to develop Alzheimer,s ... , "This new work not only provides a better ... a risk factor as an important target for therapy," said ...
... Chemotherapy and Cryosurgery are underused prostate cancer treatments in ... the US, according to Millennium Research ... Group (MRG),conducted a detailed survey of over 140 US ... Association (AUA) Annual,Meeting. Results of this study are analyzed ...
... of skin cancer self-examination, LOS ANGELES, June ... public service initiative that partners with organizations,and individuals ... health, has tapped actress Malin Akerman to educate ... cancer detection. As the #1,dermatologist recommended skincare brand ...
... WARREN, N.J., June 25 The Chubb Corporation,(NYSE: ... on Thursday,July 24, 2008 after the close of the ... shortly thereafter on Chubb,s,website at http://www.chubb.com ., ... day, Thursday, July 24,2008 at 5:00 p.m. ET hosted ...
Other Medicine News:Health News:Atchison receives Behavioral, Epidemiological and Health Services Research Award 2Health News:Best Practice Database Adds Research on New Product Commercialization 2Health News:Gene Variant May Contribute to Alzheimer's Disease 2Health News:Adoption of Minimally Invasive Prostate Cancer Treatment Options Slow 2Health News:Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection 2Health News:Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection 3Health News:Chubb Expects to Release Earnings on July 24 and Hold Conference Call on the Same Day 2
(Date:12/14/2009)... Tenn., Dec. 14 Embarrassing and sometimes uncomfortable ... National researchers are taking note of a new ... approval process. The Knoxville-based company, EDP Biotech ... revolutionary, ColoMarker, an affordable medical device doctors can use ... sample. "When you consider that 30% of colon ...
(Date:12/14/2009)... 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Drug Application (NDA) for Staccato® loxapine (AZ-004) to the ... an inhalation product candidate being developed for the rapid ... disorder. The IND for Staccato loxapine ... "AZ-004 has delivered a predictable and consistent safety and ...
(Date:12/14/2009)... Corgenix Medical Corporation (OTC Bulletin ... of diagnostic test kits, and BG Medicine, ... company, announced today a supply agreement whereby ... in enzyme-linked immunosorbent assay (ELISA) microtiter format ... seeking regulatory clearance in the United States ...
Breaking Medicine Technology:EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Study highlights HIV AIDS challenge in American prison system 58464 1Study highlights HIV AIDS challenge in American prison system 58464 2Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 1Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 2Telltale moss 10152 1
... - Oral presentation on the potent blood glucose lowering effect ... antisense inhibitors in multiple preclinical models, - Eight ... new metabolic disease ... 10 ,Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today ...
... to be Held on Monday, June 9, 2008 at 5:15 p.m. Eastern ... ... VIEW, Calif., June 9 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... with AZ-004 (Staccato(R),loxapine). AZ-004 is an inhalation product candidate being developed for,the ...
Other Medicine Technology:Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 2Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 3Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 4Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: